Sign in

CIK 0001726445

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SEER
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821153150
Phone
+1 650-453-0000
Business address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Former names
Seer Biosciences, Inc.
  1. 4 Grant or award Director acquired 9,945 shares (grant or award)
  2. 4 Grant or award Director acquired 9,945 shares (grant or award)
  3. 4 Grant or award Director acquired 9,945 shares (grant or award)
  4. 4 Grant or award Director acquired 9,945 shares (grant or award)
  5. 4 Grant or award Director acquired 5,994 shares (grant or award)
  6. 4 Grant or award Director acquired 9,945 shares (grant or award)
  7. 4 Grant or award Director acquired 5,422 shares (grant or award)
  8. 4 Grant or award Director acquired 9,945 shares (grant or award)
  9. 4 Open-market sale General Counsel and Secretary sold 8,185 shares at $8.91 ($72,923)
  10. 4 Open-market sale President & COO sold 4,441 shares at $8.06 ($35,794)
  11. 4 Open-market sale President & COO sold 52,042 shares at $10.18 ($529,933)
  12. 4 Grant or award Chief Commercial Officer acquired 26,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 5/A Insider Annual Insider Trading Report
  16. 5 Insider Annual Insider Trading Report
  17. 4 Grant or award General Counsel and Secretary acquired 62,000 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 62,000 shares (grant or award)
  19. 4 Grant or award President & COO acquired 62,000 shares (grant or award)
  20. 4 Grant or award CEO and Chair of the Board acquired 155,000 shares (grant or award)

Page 5 of 9 · 166 filings